Now more than ever, exosome and extracellular vesicles (EV) therapies are on the verge of groundbreaking clinical and commercial breakthroughs. With recent milestones like Aegle Therapeutics' clinical advances, Capricor Therapeutics' collaboration on a COVID vaccine with the NIH, and NurExone Biologics' innovations in CNS treatments. Join us at the 6th Exosome-Based Therapeutics Development Summit in September to delve into groundbreaking advancements, access exclusive clinical data, and forge pivotal partnerships to define the future of exosome drug development.

Spanning the complete development cycle of exosome therapeutics from discovery through IND filing, our summit uniquely integrates cutting-edge research with practical commercialization strategies. It stands as the sole industry meeting that bridges the gap between science and business, propelling clinical advancements.

Don't miss the chance to connect with over 130 leading experts across large pharma, biotechs, academics, gain invaluable insights, and place your work at the forefront of pharmaceutical innovation. Join us this September and advance your exosome and EV candidate with meaningful partnerships and commercialization in 2024.

Event Link here.